 |
6 Diseases |  |
0 Trials |
|
0 Trials |  |
9 News |  |
- ||| SAR 113945 / Sanofi
Enrollment change: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II (clinicaltrials.gov) - Oct 17, 2014
P2, N=130, Completed, Sponsor: Sanofi
N=85 --> 130
- ||| SAR 113945 / Sanofi
Enrollment change: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II (clinicaltrials.gov) - Feb 21, 2013
P2, N=85, Completed, Sponsor: Sanofi
N=85 --> 130 N=130 --> 85
- |||| SAR 113945 / Sanofi
Trial completion: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II (clinicaltrials.gov) - Feb 21, 2013
P2, N=85, Completed, Sponsor: Sanofi
N=130 --> 85 Recruiting --> Completed
- | SAR 113945 / Sanofi
Trial completion: Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis (clinicaltrials.gov) - Sep 27, 2012
P1, N=24, Completed, Sponsor: Sanofi
Recruiting --> Completed Active, not recruiting --> Completed
- | SAR 113945 / Sanofi
Trial completion: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I (clinicaltrials.gov) - Aug 21, 2012
P1, N=24, Completed, Sponsor: Sanofi
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| SAR 113945 / Sanofi
New P2 trial: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II (clinicaltrials.gov) - May 13, 2012
P2, N=85, Completed, Sponsor: Sanofi
- | SAR 113945 / Sanofi
New P1 trial: Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis (clinicaltrials.gov) - Jan 16, 2012
P1, N=24, Completed, Sponsor: Sanofi
- | SAR 113945 / Sanofi
New P1 trial: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I (clinicaltrials.gov) - Oct 31, 2011
P1, N=24, Completed, Sponsor: Sanofi